Sernova Biotherapeutics (OTCMKTS:SEOVF) Posts Earnings Results

Sernova Biotherapeutics (OTCMKTS:SEOVF) posted its quarterly earnings results on Friday. The company reported ($0.01) earnings per share (EPS) for the quarter, Zacks reports.

Sernova Biotherapeutics Trading Down 0.1%

Sernova Biotherapeutics stock traded down $0.00 during trading hours on Friday, reaching $0.09. 33,000 shares of the stock were exchanged, compared to its average volume of 27,487. The stock has a 50 day moving average of $0.11 and a two-hundred day moving average of $0.12. The company has a market cap of $31.37 million, a P/E ratio of -2.37 and a beta of 1.08. Sernova Biotherapeutics has a twelve month low of $0.09 and a twelve month high of $0.18.

About Sernova Biotherapeutics

Sernova Biotherapeutics is a clinical‐stage biotechnology company focused on developing and commercializing cell‐based therapeutic technologies for patients with chronic and life‐threatening diseases. Headquartered in London, Ontario, Canada, the firm is advancing an implantable device platform designed to support the long-term survival and function of therapeutic cells. The company’s lead product candidate, known as the Cell Pouch System, is engineered to create a vascularized environment in which transplanted cells can thrive, with an initial emphasis on treating patients with type 1 diabetes.

In its core program, Sernova has initiated a Phase I/II clinical trial evaluating the safety and efficacy of the Cell Pouch System in individuals with type 1 diabetes who require islet cell transplantation.